Brief: Arcus Biosciences Q3 revenue USD 32 million vs. IBES estimate USD 27.3 million
07/11/2023 21:53
Nov 7 (Reuters) - Arcus Biosciences Q3 net income USD -71 million. * Q3 operating income USD -80 million * Q3 pretax profit USD -69 million * Q3 operating expenses USD 112 million * Q3 revenue USD 32 million vs. IBES estimate USD 27.3 million
Recent news on Arcus Biosciences
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Arcus Biosciences tumbles on $250 mln share sale
Brief: Arcus Biosciences Announces Pricing Of $250 Million Public Offering Of Common Stock
Arcus Biosciences drops after starting stock offering